期刊文献+

铜绿假单胞菌制剂治疗妇科癌性腹腔积液的临床报告 被引量:2

下载PDF
导出
摘要 目的:探讨难治性癌性腹腔积液有效的治疗方法。方法:恶性腹腔积液患者腹腔穿刺后,予地塞米松预防发热,并注入铜绿假单胞菌制剂,每周1次,连续2~3次。结果:21例患者腹腔注入33次,每例1~3次,平均1.6次,有效率80.9%。3例腹部出现隐痛不适,1例出现肠痉挛,4例腹腔注入地塞米松后仍出现中低度发热。结论:应用铜绿假单胞菌制剂治疗癌性腹腔积液,具有一定效果,副反应较轻微,建议临床进一步推广应用。
出处 《中国医药导报》 CAS 2008年第8期55-55,共1页 China Medical Herald
  • 相关文献

参考文献3

二级参考文献7

  • 1吕品,邓玉兰,丁桂凤.抗Thy-1、L3T4、Lyt-2单克隆抗体的产生和鉴定[J].免疫学杂志,1989,5(2):6-9. 被引量:11
  • 2王金万,中国新药杂志,1993年,2卷,44页
  • 3许佩珉,肿瘤防治研究,1991年,19卷,68页
  • 4王金万,实用肿瘤杂志,1989年,4卷,74页
  • 5张玲,中国免疫学杂志,1985年,1期,25页
  • 6周正任,李长荣,李晓菲,刘桂芬,于维福,赵惠远,马树俊.肿瘤病人外周血T细胞及其亚群和NK细胞活性变化的研究[J]中国免疫学杂志,1987(05).
  • 7于永利,杨贵贞.人参花总皂甙在体外对小鼠NK活性的影响[J]中国免疫学杂志,1985(02).

共引文献52

同被引文献33

  • 1Ba, Ming-Chen,Cui, Shu-Zhong,Lin, Sheng-Qu,Tang, Yun-Qiang,Wu, Yin-Bing,Wang, Bin,Zhang, Xiang-Liang.Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites[J].World Journal of Gastroenterology,2010,16(15):1901-1907. 被引量:50
  • 2张明策,牟希亚.PA-MSHA菌苗的抗肿瘤活性和免疫调节作用[J].上海免疫学杂志,1994,14(5):268-271. 被引量:31
  • 3Sayag-Beaujard AC,Francois Y,Glehe O. Treatment of peritoneal carcinomatosisin patients with digestive cancerswith combination of intraperitoneal hyperther2mia and mitomycin C[J].BULLETIN DU CANCER,2004,(5):E113-E132.
  • 4Wang L,Liu X,Wang H. Correlation of the expression of vascular endothelial growth factor and its receptors with microvessel density in ovarian cancer[J].Oncol Lett,2013,(1):175-180.
  • 5Iyer R,Chow J,El-Bahrawy M. Meigs syndrome presenting with axillary vein thrombosis and lymphadenopathy:a case report[J].J Med Case Rep,2013,(1):182.
  • 6Voutsas IF,Pistamaltzian N,Tsiatas ML. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice[J].EUROPEAN JOURNAL OF CANCER,2013,(7):1706-1714.
  • 7Petrelli F,Borgonovo K,Lonati V. Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer[J].Target Oncol,2013,(4):291-294.
  • 8Chaklader M,Das P,Pereira JA. 17-AAG mediated targeting of Hsp90 limits tert activity in peritoneal sarcoma related malignant ascites by downregulating cyclin D1 during cell cycle entry[J].EXPERIMENTAL ONCOLOGY,2012,(2):90-96.
  • 9Eskander RN,Tewari KS. Emerging treatment options for management of malignant ascites in patients with ovarian cancer[J].Int J Womens Health,2012.395-404.
  • 10Huang XE,Wei GL,Huo JG. Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites[J].Asian Pacific Journal of Cancer Prev,2013,(4):2611-2614.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部